Label Changes for:
Zenpep (Pancrelipase) Delayed-release Capsules
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2013
- Postmarketing data for Zenpep have been available since 2009. The following adverse reactions have been identified during post-approval use of Zenpep…